MLYS Financials
Mineralys Therapeutics, Inc. Common Stock - Financial statements & key metrics
Stock Price
$31.93
Market Cap
$2.53B
EPS
$-2.92
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$0.00
Gross Profit
$-43000.00
Operating Income
$-192.40M
Net Income
$-177.81M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$205.90M
Total Liabilities
$14.65M
Shareholders Equity
$191.26M
Cash & Equivalents
$114.09M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-166.31M
CapEx
$96000
Free Cash Flow
$-166.41M
Profitability Metrics
ROE
-0.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MLYS revenue?
MLYS's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is MLYS profitable?
MLYS reported a loss of $177.81M in the most recent quarter.
What is MLYS market cap?
MLYS has a market capitalization of $2.53B, making it a mid-cap stock.
Does MLYS have debt?
View MLYS's balance sheet for debt information.
What is MLYS cash flow?
MLYS's most recent quarterly free cash flow was $-166.41M.